Finance

Lists
KAEF:IDX
Kimia Farma (Persero) Tbk PT
IDR 350.00
0.00%
(0.00) 1D
Nov 6, 4:07:37 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KAEF...
Open
IDR 350
High
IDR 352
Low
IDR 342
Mkt. cap
1.95T
Avg. vol.
933.33K
Volume
289.50K
52-wk high
IDR 785
52-wk low
IDR 324
EPS
-IDR 39
Shares outstanding
5.57B
No. of employees
9K
Open
IDR 350
High
IDR 352
Low
IDR 342
Mkt. cap
1.95T
Avg. vol.
933.33K
Volume
289.50K
52-wk high
IDR 785
52-wk low
IDR 324
EPS
-IDR 39
Shares outstanding
5.57B
No. of employees
9K
News stories
From web sources and news partners
Profile
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta. Wikipedia
About Kimia Farma (Persero) Tbk PT
CEO-
Employees9.22K
FoundedAug 16, 1971
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.22T
2.03T
2.67T
2.37T
Cost of goods sold
1.56T
1.29T
1.86T
1.40T
Cost of revenue
1.56T
1.29T
1.86T
1.40T
Research and development expenses
7.54B
3.20B
10.39B
-13.59B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
663.87B
640.94B
620.33B
1.08T
Operating expense
877.17B
669.20B
722.39B
900.54B
Total operating expenses
2.44T
1.96T
2.59T
2.30T
Operating income
-222.99B
67.93B
84.77B
75.81B
Other non operating income
173.66B
159.00B
-26.56B
8.13B
EBT including unusual items
-223.75B
127.96B
-60.16B
-57.52B
EBT excluding unusual items
-260.76B
127.95B
-60.19B
-57.49B
Income tax expense
-14.50B
4.32B
9.40B
9.47B
Effective tax rate
6.48%
3.37%
-15.62%
-16.46%
Other operating expenses
-36.20B
-12.78B
-9.74B
-25.16B
Net income
-155.23B
74.45B
-64.12B
-72.34B
Net profit margin
-7.01%
3.67%
-2.40%
-3.05%
Earnings per share
-
-
-
-
Interest and investment income
10.77B
2.87B
8.13B
-
Interest expense
-221.53B
-110.15B
-125.81B
-132.68B
Net interest expenses
-210.75B
-107.28B
-117.68B
-132.68B
Depreciation and amortization charges
175.98B
37.85B
101.42B
-139.27B
EBITDA
-86.40B
125.64B
165.62B
156.67B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps